▶ 調査レポート

口唇ヘルペス治療の世界市場(~2026年)

• 英文タイトル:Global Herpes Labialis Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。口唇ヘルペス治療の世界市場(~2026年) / Global Herpes Labialis Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY12178資料のイメージです。• レポートコード:MRC2-11QY12178
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は口唇ヘルペス治療のグローバル市場について調査・分析したレポートです。種類別(アシクロビル、バラシクロビル、ファムシクロビル、ペンシクロビル、ドコサノール)市場規模、用途別(局所、経口)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別口唇ヘルペス治療の競争状況、市場シェア
・世界の口唇ヘルペス治療市場:種類別市場規模 2015年-2020年(アシクロビル、バラシクロビル、ファムシクロビル、ペンシクロビル、ドコサノール)
・世界の口唇ヘルペス治療市場:種類別市場規模予測 2021年-2026年(アシクロビル、バラシクロビル、ファムシクロビル、ペンシクロビル、ドコサノール)
・世界の口唇ヘルペス治療市場:用途別市場規模 2015年-2020年(局所、経口)
・世界の口唇ヘルペス治療市場:用途別市場規模予測 2021年-2026年(局所、経口)
・北米の口唇ヘルペス治療市場分析:米国、カナダ
・ヨーロッパの口唇ヘルペス治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの口唇ヘルペス治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の口唇ヘルペス治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの口唇ヘルペス治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Teva、Abbott、Sun、Mylan、Pfizer、GlaxoSmithKline、Dr. Reddy's、Novartis
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Herpes Labialis Treatment Market
The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Herpes Labialis Treatment Scope and Market Size
Herpes Labialis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Labialis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Teva
Abbott
Sun
Mylan
Pfizer
GlaxoSmithKline
Dr. Reddy’s
Novartis

Market segment by Type, the product can be split into
Acyclovir
Valacyclovir
Famciclovir
Penciclovir
Docosanol
Market segment by Application, split into
Topical
Oral

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Herpes Labialis Treatment Revenue
1.4 Market by Type
1.4.1 Global Herpes Labialis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acyclovir
1.4.3 Valacyclovir
1.4.4 Famciclovir
1.4.5 Penciclovir
1.4.6 Docosanol
1.5 Market by Application
1.5.1 Global Herpes Labialis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Topical
1.5.3 Oral
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Herpes Labialis Treatment Market Perspective (2015-2026)
2.2 Global Herpes Labialis Treatment Growth Trends by Regions
2.2.1 Herpes Labialis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Herpes Labialis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Herpes Labialis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Herpes Labialis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Herpes Labialis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Herpes Labialis Treatment Players by Market Size
3.1.1 Global Top Herpes Labialis Treatment Players by Revenue (2015-2020)
3.1.2 Global Herpes Labialis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Herpes Labialis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Herpes Labialis Treatment Market Concentration Ratio
3.2.1 Global Herpes Labialis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Herpes Labialis Treatment Revenue in 2019
3.3 Herpes Labialis Treatment Key Players Head office and Area Served
3.4 Key Players Herpes Labialis Treatment Product Solution and Service
3.5 Date of Enter into Herpes Labialis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Herpes Labialis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Herpes Labialis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Herpes Labialis Treatment Market Size by Application (2015-2020)
5.2 Global Herpes Labialis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Herpes Labialis Treatment Market Size (2015-2020)
6.2 Herpes Labialis Treatment Key Players in North America (2019-2020)
6.3 North America Herpes Labialis Treatment Market Size by Type (2015-2020)
6.4 North America Herpes Labialis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Herpes Labialis Treatment Market Size (2015-2020)
7.2 Herpes Labialis Treatment Key Players in Europe (2019-2020)
7.3 Europe Herpes Labialis Treatment Market Size by Type (2015-2020)
7.4 Europe Herpes Labialis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Herpes Labialis Treatment Market Size (2015-2020)
8.2 Herpes Labialis Treatment Key Players in China (2019-2020)
8.3 China Herpes Labialis Treatment Market Size by Type (2015-2020)
8.4 China Herpes Labialis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Herpes Labialis Treatment Market Size (2015-2020)
9.2 Herpes Labialis Treatment Key Players in Japan (2019-2020)
9.3 Japan Herpes Labialis Treatment Market Size by Type (2015-2020)
9.4 Japan Herpes Labialis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Herpes Labialis Treatment Market Size (2015-2020)
10.2 Herpes Labialis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Herpes Labialis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Herpes Labialis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Herpes Labialis Treatment Market Size (2015-2020)
11.2 Herpes Labialis Treatment Key Players in India (2019-2020)
11.3 India Herpes Labialis Treatment Market Size by Type (2015-2020)
11.4 India Herpes Labialis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Herpes Labialis Treatment Market Size (2015-2020)
12.2 Herpes Labialis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Herpes Labialis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Herpes Labialis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Teva
13.1.1 Teva Company Details
13.1.2 Teva Business Overview
13.1.3 Teva Herpes Labialis Treatment Introduction
13.1.4 Teva Revenue in Herpes Labialis Treatment Business (2015-2020))
13.1.5 Teva Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Herpes Labialis Treatment Introduction
13.2.4 Abbott Revenue in Herpes Labialis Treatment Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Sun
13.3.1 Sun Company Details
13.3.2 Sun Business Overview
13.3.3 Sun Herpes Labialis Treatment Introduction
13.3.4 Sun Revenue in Herpes Labialis Treatment Business (2015-2020)
13.3.5 Sun Recent Development
13.4 Mylan
13.4.1 Mylan Company Details
13.4.2 Mylan Business Overview
13.4.3 Mylan Herpes Labialis Treatment Introduction
13.4.4 Mylan Revenue in Herpes Labialis Treatment Business (2015-2020)
13.4.5 Mylan Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Herpes Labialis Treatment Introduction
13.5.4 Pfizer Revenue in Herpes Labialis Treatment Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Herpes Labialis Treatment Introduction
13.6.4 GlaxoSmithKline Revenue in Herpes Labialis Treatment Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Dr. Reddy’s
13.7.1 Dr. Reddy’s Company Details
13.7.2 Dr. Reddy’s Business Overview
13.7.3 Dr. Reddy’s Herpes Labialis Treatment Introduction
13.7.4 Dr. Reddy’s Revenue in Herpes Labialis Treatment Business (2015-2020)
13.7.5 Dr. Reddy’s Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Herpes Labialis Treatment Introduction
13.8.4 Novartis Revenue in Herpes Labialis Treatment Business (2015-2020)
13.8.5 Novartis Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Herpes Labialis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Herpes Labialis Treatment Revenue
Table 3. Ranking of Global Top Herpes Labialis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Herpes Labialis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acyclovir
Table 6. Key Players of Valacyclovir
Table 7. Key Players of Famciclovir
Table 8. Key Players of Penciclovir
Table 9. Key Players of Docosanol
Table 10. Global Herpes Labialis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Herpes Labialis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Herpes Labialis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Herpes Labialis Treatment Market Share by Regions (2015-2020)
Table 14. Global Herpes Labialis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Herpes Labialis Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Herpes Labialis Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Herpes Labialis Treatment Players
Table 21. Global Herpes Labialis Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Herpes Labialis Treatment Market Share by Players (2015-2020)
Table 23. Global Top Herpes Labialis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Labialis Treatment as of 2019)
Table 24. Global Herpes Labialis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Herpes Labialis Treatment Product Solution and Service
Table 27. Date of Enter into Herpes Labialis Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Herpes Labialis Treatment Market Size Share by Type (2015-2020)
Table 31. Global Herpes Labialis Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Herpes Labialis Treatment Market Size Share by Application (2015-2020)
Table 33. Global Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Herpes Labialis Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Herpes Labialis Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Herpes Labialis Treatment Market Share (2019-2020)
Table 37. North America Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Herpes Labialis Treatment Market Share by Type (2015-2020)
Table 39. North America Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Herpes Labialis Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Herpes Labialis Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Herpes Labialis Treatment Market Share (2019-2020)
Table 43. Europe Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Herpes Labialis Treatment Market Share by Type (2015-2020)
Table 45. Europe Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Herpes Labialis Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Herpes Labialis Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Herpes Labialis Treatment Market Share (2019-2020)
Table 49. China Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Herpes Labialis Treatment Market Share by Type (2015-2020)
Table 51. China Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Herpes Labialis Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Herpes Labialis Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Herpes Labialis Treatment Market Share (2019-2020)
Table 55. Japan Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Herpes Labialis Treatment Market Share by Type (2015-2020)
Table 57. Japan Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Herpes Labialis Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Herpes Labialis Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Herpes Labialis Treatment Market Share (2019-2020)
Table 61. Southeast Asia Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Herpes Labialis Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Herpes Labialis Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Herpes Labialis Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Herpes Labialis Treatment Market Share (2019-2020)
Table 67. India Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Herpes Labialis Treatment Market Share by Type (2015-2020)
Table 69. India Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Herpes Labialis Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Herpes Labialis Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Herpes Labialis Treatment Market Share (2019-2020)
Table 73. Central & South America Herpes Labialis Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Herpes Labialis Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Herpes Labialis Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Herpes Labialis Treatment Market Share by Application (2015-2020)
Table 77. Teva Company Details
Table 78. Teva Business Overview
Table 79. Teva Product
Table 80. Teva Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 81. Teva Recent Development
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Product
Table 85. Abbott Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 86. Abbott Recent Development
Table 87. Sun Company Details
Table 88. Sun Business Overview
Table 89. Sun Product
Table 90. Sun Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 91. Sun Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Product
Table 95. Mylan Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 96. Mylan Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Product
Table 100. Pfizer Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 101. Pfizer Recent Development
Table 102. GlaxoSmithKline Company Details
Table 103. GlaxoSmithKline Business Overview
Table 104. GlaxoSmithKline Product
Table 105. GlaxoSmithKline Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 106. GlaxoSmithKline Recent Development
Table 107. Dr. Reddy's Company Details
Table 108. Dr. Reddy's Business Overview
Table 109. Dr. Reddy's Product
Table 110. Dr. Reddy's Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 111. Dr. Reddy's Recent Development
Table 112. Novartis Business Overview
Table 113. Novartis Product
Table 114. Novartis Company Details
Table 115. Novartis Revenue in Herpes Labialis Treatment Business (2015-2020) (Million US$)
Table 116. Novartis Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Labialis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acyclovir Features
Figure 3. Valacyclovir Features
Figure 4. Famciclovir Features
Figure 5. Penciclovir Features
Figure 6. Docosanol Features
Figure 7. Global Herpes Labialis Treatment Market Share by Application: 2020 VS 2026
Figure 8. Topical Case Studies
Figure 9. Oral Case Studies
Figure 10. Herpes Labialis Treatment Report Years Considered
Figure 11. Global Herpes Labialis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Herpes Labialis Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Herpes Labialis Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Herpes Labialis Treatment Market Share by Players in 2019
Figure 16. Global Top Herpes Labialis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Labialis Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Herpes Labialis Treatment Revenue in 2019
Figure 18. North America Herpes Labialis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Herpes Labialis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Herpes Labialis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Herpes Labialis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Herpes Labialis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Herpes Labialis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Herpes Labialis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed